======= NAGA =======
== Gene Information ==
* **Official Symbol**: N/AGA
* **Official Name**: alpha-N-acetylgalactosaminidase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4668|4668]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P17050|P17050]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NAGA&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NAGA|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/104170|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease). [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Removes terminal alpha-N-acetylgalactosamine residues from glycolipids and glycopeptides. Required for the breakdown of glycolipids. {ECO:0000269|PubMed:9741689}.
|Melibiase|
|alpha-N-acetylgalactosaminidase activity|
|alpha-galactosidase activity|
|glycosylceramide catabolic process|
|glycoside catabolic process|
|glycosphingolipid catabolic process|
|glycolipid catabolic process|
|glycosylceramide metabolic process|
|ceramide catabolic process|
|glycoside metabolic process|
|sphingolipid catabolic process|
|membrane lipid catabolic process|
|glycosyl compound catabolic process|
|oligosaccharide metabolic process|
|glycosphingolipid metabolic process|
|ceramide metabolic process|
|glycolipid metabolic process|
|liposaccharide metabolic process|
|carbohydrate catabolic process|
|glycosyl compound metabolic process|
|sphingolipid metabolic process|
|carbohydrate derivative catabolic process|
|cellular lipid catabolic process|
|membrane lipid metabolic process|
|lysosome|
|lipid catabolic process|
|carbohydrate metabolic process|
|cellular amide metabolic process|
|protein homodimerization activity|
|cellular lipid metabolic process|
|carbohydrate derivative metabolic process|
|organonitrogen compound catabolic process|
|lipid metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|1.81|
|[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|1.89|
|[[:results:exp532|TIC10 10μM R08 exp532]]|1.94|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10017
* **Expression level (log2 read counts)**: 5.12
{{:chemogenomics:nalm6 dist.png?nolink |}}